ArticleFrontiers in oncology2022

Bruceine H Mediates EGFR-TKI Drug Persistence in NSCLC by Notch3-Dependent β-Catenin Activating FOXO3a Signaling.

Jiahui Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.